IsoPlexis Announces Research Collaboration with Nektar Therapeutics
IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced its collaboration with Nektar Therapeutics. The…
Read More...
Read More...
